Status:
COMPLETED
Comparison of Balloon Kyphoplasty and Vertebroplasty in Subacute Osteoporotic Vertebral Fractures
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Osteoporotic Vertebral Fracture
Between T5 and L5
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
This study aims to compare two treatments in subacute (more than 6 week duration) non-traumatic (usually osteoporotic) vertebral fractures. The two treatments are the following: 1. Vertebroplasty con...
Detailed Description
Vertebral compression fractures can occur at any level in the vertebral column but the most frequent ones occur at the thoracic (T8-T12) and lumbar spine (L1 and L4). Multiple vertebrae are often conc...
Eligibility Criteria
Inclusion
- Patient is able to undergo the vertebroplasty or Balloon kyphoplasty procedure
- Patient has read and sign the informed consent
- Male or female, 50 years or older
- One or two non-traumatic vertebral fracture(s):
- Of osteoporotic origin (low speed trauma such as fall from his own height or less than 80 cm)
- Fracture(s) older than 6 weeks duration after the onset of pain related to the fracture· The fracture(s) exhibit(s) high signal intensity on T2-weighted images and a benign appearance at MRI
- Persistent pain despite medical treatment according to VAS ≥ 5 or a last resort to morphine treatment
- The patient will be able to receive the selected protocol treatment within 15 days after treatment randomization.
- The benign nature of the vertebral fracture has to be confirmed by the results of the biopsy performed during vertebroplasty or balloon kyphoplasty.
Exclusion
- Patient with a vertebral fracture of less than 6 week duration after onset of fracture-related symptoms.
- Neurological signs related to the vertebral fracture to treat
- History of surgical or percutaneous spine treatment except simple discectomy at a single or multiple vertebral levels with no residual pain.
- Patient with more than 2 fractures corresponding to the inclusion criteria (old fractures are not taken into account)
- Known allergy to a contrast media or to one of the cement components used for kyphoplasty.
- More than two recent vertebral fractures
- Current infection
- Impossibility to perform the percutaneous approach of the vertebra to treat.
- Known allergy to a contrast media or to one of the cement components used for kyphoplasty.
- Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat.
- Vertebral fracture with loss of 90%or more of the vertebral body height
- Malignant and traumatic vertebral fractures
- Contraindication to MRI :
- Metallic implant : pace-maker, no auditive implant , metallic vascular or movable cardiac device
- Metallic surgical clips Claustrophobia
- Evolutive cardiac disease nonreactive to medical treatment
- Patient presenting a non correctable spontaneous or therapeutic coagulation disorder.
- Presence of an unexplained biological inflammatory syndrome with VS≥20
- Non compliant patient: Impossibility to participate to the study and to be followed up for 1 year.
- Pregnant or breast feeding women
- Patient not affiliated to social security
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00749086
Start Date
December 1 2007
End Date
June 1 2012
Last Update
December 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Radiologie, Hôpital Lariboisière
Paris, France, 75010